Ian McKnight is researching the biological mechanisms underlying allergies, with the goal of developing new therapeutics to ...

Roger Hajjar, ’86, is the inaugural director of the Gene and Cell Therapy Institute at Mass General Brigham and the president, chief medical officer, and co-founder of Medera, a clinical-stage ...